Atrys Health Statistics

Total Valuation

Atrys Health has a market cap or net worth of EUR 226.29 million. The enterprise value is 403.54 million.

Market Cap	226.29M
Enterprise Value	403.54M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Atrys Health has 75.94 million shares outstanding. The number of shares has increased by 49.29% in one year.

Current Share Class	n/a
Shares Outstanding	75.94M
Shares Change (YoY)	+49.29%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	12.77%
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.00
PB Ratio	0.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.98, with an EV/FCF ratio of -322.83.

EV / Earnings	-12.70
EV / Sales	1.79
EV / EBITDA	10.98
EV / EBIT	52.26
EV / FCF	-322.83

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.78.

Current Ratio	0.89
Quick Ratio	0.76
Debt / Equity	0.78
Debt / EBITDA	5.37
Debt / FCF	-157.97
Interest Coverage	0.33

Financial Efficiency

Return on equity (ROE) is -11.73% and return on invested capital (ROIC) is 0.97%.

Return on Equity (ROE)	-11.73%
Return on Assets (ROA)	0.80%
Return on Invested Capital (ROIC)	0.97%
Return on Capital Employed (ROCE)	1.59%
Revenue Per Employee	107,955
Profits Per Employee	-15,247
Employee Count	2,061
Asset Turnover	0.37
Inventory Turnover	97.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.93% in the last 52 weeks. The beta is 0.76, so Atrys Health's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-2.93%
50-Day Moving Average	3.39
200-Day Moving Average	3.35
Relative Strength Index (RSI)	31.64
Average Volume (20 Days)	60,837

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Atrys Health had revenue of EUR 224.98 million and -31.77 million in losses. Loss per share was -0.42.

Revenue	224.98M
Gross Profit	67.04M
Operating Income	7.72M
Pretax Income	-33.47M
Net Income	-31.77M
EBITDA	36.77M
EBIT	7.72M
Loss Per Share	-0.42

Full Income Statement

Balance Sheet

The company has 20.37 million in cash and 197.47 million in debt, giving a net cash position of -177.10 million or -2.33 per share.

Cash & Cash Equivalents	20.37M
Total Debt	197.47M
Net Cash	-177.10M
Net Cash Per Share	-2.33
Equity (Book Value)	253.24M
Book Value Per Share	3.36
Working Capital	-10.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.00 million and capital expenditures -4.25 million, giving a free cash flow of -1.25 million.

Operating Cash Flow	3.00M
Capital Expenditures	-4.25M
Free Cash Flow	-1.25M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 29.80%, with operating and profit margins of 3.43% and -14.12%.

Gross Margin	29.80%
Operating Margin	3.43%
Pretax Margin	-14.88%
Profit Margin	-14.12%
EBITDA Margin	16.34%
EBIT Margin	3.43%
FCF Margin	n/a

Dividends & Yields

Atrys Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.29%
Shareholder Yield	-49.29%
Earnings Yield	-14.04%
FCF Yield	-0.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a